Propanc Biopharma Inc (PPCB) vs Windtree Therapeutics, Inc. (WINT)

Propanc Biopharma Inc and Windtree Therapeutics, Inc. are both Biotechnology companies. Propanc Biopharma Inc and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.1M). Windtree Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Propanc Biopharma Inc trades at 0.0×. Across the 9 metrics below, Propanc Biopharma Inc leads on 6 and Windtree Therapeutics, Inc. on 3.

Valuation

Metric PPCB WINT Biotechnology median
P/E 0.00 n/m 7.88
P/S n/m n/m 11.47
P/B 0.06 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 63.80 10.73
Earnings yield 257,474.29% 0.00% (28.84%)
Free cash flow yield (739.21%) 0.00% (23.03%)

Profitability

Metric PPCB WINT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.20%) 1,356.23% (57.72%)
Return on assets (104.68%) (210.34%) (49.22%)
Return on invested capital (116.59%) (386.34%) 0.00%

Growth

Metric PPCB WINT Biotechnology median
Revenue growth (TTM) — (68.35%) 5.64%
EPS growth (last fiscal year) 98.81% 97.79% —
Revenue growth, 5-year CAGR — (41.28%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PPCB WINT Biotechnology median
Debt to equity 0.05 (1.48) 0.00
Current ratio 2.37 0.33 4.73
Net debt to EBITDA (0.01) 0.03 0.96

Dividend

Metric PPCB WINT Biotechnology median
Dividend yield — 4.38% 2.10%
Payout ratio — 0.00 0.00

Size

Metric PPCB WINT Biotechnology median
Market cap 2.14m 2.35m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack